|
1
|
Roomruangwong C, Anderson G, Berk M,
Stoyanov D, Carvalho AF and Maes M: A neuro-immune, neuro-oxidative
and neuro-nitrosative model of prenatal and postpartum depression.
Prog Neuropsychopharmacol Biol Psychiatry. 81:262–274. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roeleveld DM and Koenders MI: The role of
the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis
pathogenesis and developments in cytokine immunotherapy. Cytokine.
74:101–107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang H-L, Zheng X-Y and Zhu J:
Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and
experimental autoimmune neuritis. Cytokine Growth Factor Rev.
24:443–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chakraborty S, Kubatzky KF and Mitra DK:
An update on interleukin-9: From its cellular source and signal
transduction to its role in immunopathogenesis. Int J Mol Sci.
20:21132019. View Article : Google Scholar
|
|
5
|
Dujmovic I, Mangano K, Pekmezovic T,
Quattrocchi C, Mesaros S, Stojsavljevic N, Nicoletti F and Drulovic
J: The analysis of IL-1 beta and its naturally occurring inhibitors
in multiple sclerosis: The elevation of IL-1 receptor antagonist
and IL-1 receptor type II after steroid therapy. J Neuroimmunol.
207:101–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ayakannu R, Abdullah NA, Radhakrishnan AK,
Lechimi Raj V and Liam CK: Relationship between various cytokines
implicated in asthma. Hum Immunol. May 1–2019.(Epub ahead of
print). doi: 10.1016/j.humimm.2019.04.018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nicoletti F, Mancuso G, Cusumano V, Di
Marco R, Zaccone P, Bendtzen K and Teti G: Prevention of
endotoxin-induced lethality in neonatal mice by interleukin-13. Eur
J Immunol. 27:1580–1583. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Conway TF, Hammer L, Furtado S, Mathiowitz
E, Nicoletti F, Mangano K, Egilmez NK and Auci DL: Oral delivery of
particulate transforming growth factor beta 1 and all-trans
retinoic acid reduces gut inflammation in murine models of
inflammatory bowel disease. J Crohn's Colitis. 9:647–658. 2015.
View Article : Google Scholar
|
|
9
|
Nicoletti F, Di Marco R, Patti F, Reggio
E, Nicoletti A, Zaccone P, Stivala F, Meroni PL and Reggio A: Blood
levels of transforming growth factor-beta 1 (TGF-beta1) are
elevated in both relapsing remitting and chronic progressive
multiple sclerosis (MS) patients and are further augmented by
treatment with interferon-beta 1b (IFN-beta1b). Clin Exp Immunol.
113:96–99. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barcellini W, Rizzardi GP, Borghi MO,
Nicoletti F, Fain C, Del Papa N and Meroni PL: In vitro type-1 and
type-2 cytokine production in systemic lupus erythematosus: Lack of
relationship with clinical disease activity. Lupus. 5:139–145.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raghupathy R: Pregnancy: Success and
failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 13:219–227.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Christian LM, Franco A, Glaser R and Iams
JD: Depressive symptoms are associated with elevated serum
proinflammatory cytokines among pregnant women. Brain Behav Immun.
23:750–754. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Simpson W, Steiner M, Coote M and Frey BN:
Relationship between inflammatory biomarkers and depressive
symptoms during late pregnancy and the early postpartum period: A
longitudinal study. Br J Psychiatry. 38:190–196. 2016. View Article : Google Scholar
|
|
14
|
Karlsson L, Nousiainen N, Scheinin NM,
Maksimow M, Salmi M, Lehto SM, Tolvanen M, Lukkarinen H and
Karlsson H: Cytokine profile and maternal depression and anxiety
symptoms in mid-pregnancy-the FinnBrain Birth Cohort Study. Arch
Women Ment Health. 20:39–48. 2017. View Article : Google Scholar
|
|
15
|
Meylan F and Siegel RM: TNF superfamily
cytokines in the promotion of Th9 differentiation and
immunopathology. Semin Immunopathol. 39:21–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leff Gelman P, Mancilla-Herrera I,
Flores-Ramos M, Saravia Takashima MF, Cruz Coronel FM, Cruz Fuentes
C, Pérez Molina A, Hernández-Ruiz J, Silva-Aguilera FS,
Farfan-Labonne B, et al: The cytokine profile of women with severe
anxiety and depression during pregnancy. BMC Psychiatry.
19:1042019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mehta D, Newport DJ, Frishman G, Kraus L,
Rex-Haffner M, Ritchie JC, Lori A, Knight BT, Stagnaro E, Ruepp A,
et al: Early predictive biomarkers for postpartum depression point
to a role for estrogen receptor signaling. Psychol Med.
44:2309–2322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lobbestael J, Leurgans M and Arntz A:
Inter-rater reliability of the structured clinical interview for
DSM-IV axis I disorders (SCID I) and axis II disorders (SCID II).
Clin Psychol Psychother. 18:75–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Richter P, Werner J, Heerlein A, Kraus A
and Sauer H: On the validity of the Beck Depression Inventory. A
review. Psychopathology. 31:160–168. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bobo WV, Angleró GC, Jenkins G,
Hall-Flavin DK, Weinshilboum R and Biernacka JM: Validation of the
17-item Hamilton Depression Rating Scale definition of response for
adults with major depressive disorder using equipercentile linking
to Clinical Global Impression scale ratings: Analysis of
Pharmacogenomic Research Network Antidepressant Medication
Pharmacogenomic Study (PGRN-AMPS) data. Hum Psychopharmacol.
31:185–192. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Usuda K, Nishi D, Okazaki E, Makino M and
Sano Y: Optimal cut-off score of the Edinburgh Postnatal Depression
Scale for major depressive episode during pregnancy in Japan.
Psychiatry Clin Neurosci. 71:836–842. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gustafsson M, Edström M, Gawel D, Nestor
CE, Wang H, Zhang H, Barrenäs F, Tojo J, Kockum I, Olsson T, et al:
Integrated genomic and prospective clinical studies show the
importance of modular pleiotropy for disease susceptibility,
diagnosis and treatment. Genome Med. 6:172014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fagone P, Mazzon E, Cavalli E, Bramanti A,
Petralia MC, Mangano K, Al-Abed Y, Bramati P and Nicoletti F:
Contribution of the macrophage migration inhibitory factor
superfamily of cytokines in the pathogenesis of preclinical and
human multiple sclerosis: In silico and in vivo evidences. J
Neuroimmunol. 322:46–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mangano K, Cavalli E, Mammana S, Basile
MS, Caltabiano R, Pesce A, Puleo S, Atanasov AG, Magro G, Nicoletti
F, et al: Involvement of the Nrf2/HO-1/CO axis and therapeutic
intervention with the CO-releasing molecule CORM-A1, in a murine
model of autoimmune hepatitis. J Cell Physiol. 233:4156–4165. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mammana S, Bramanti P, Mazzon E, Cavalli
E, Basile MS, Fagone P, Petralia MC, McCubrey JA, Nicoletti F and
Mangano K: Preclinical evaluation of the PI3K/Akt/mTOR pathway in
animal models of multiple sclerosis. Oncotarget. 9:8263–8277. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fagone P, Muthumani K, Mangano K, Magro G,
Meroni PL, Kim JJ, Sardesai NY, Weiner DB and Nicoletti F: VGX-1027
modulates genes involved in lipopolysaccharide-induced Toll-like
receptor 4 activation and in a murine model of systemic lupus
erythematosus. Immunology. 142:594–602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fagone P, Mazzon E, Mammana S, Di Marco R,
Spinasanta F, Basile MS, Petralia MC, Bramanti P, Nicoletti F and
Mangano K: Identification of CD4+ T cell biomarkers for
predicting the response of patients with relapsing remitting
multiple sclerosis to natalizumab treatment. Mol Med Rep.
20:678–684. 2019.PubMed/NCBI
|
|
28
|
Nicoletti F, Mazzon E, Fagone P, Mangano
K, Mammana S, Cavalli E, Basile MS, Bramanti P, Scalabrino G, Lange
A, et al: Prevention of clinical and histological signs of
MOG-induced experimental allergic encephalomyelitis by prolonged
treatment with recombinant human EGF. J Neuroimmunol. 332:224–232.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Presti M, Mazzon E, Basile MS, Petralia
MC, Bramanti A, Colletti G, Bramanti P, Nicoletti F and Fagone P:
Overexpression of macrophage migration inhibitory factor and
functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in
glioblastoma. Oncol Lett. 16:2881–2886. 2018.PubMed/NCBI
|
|
30
|
Fagone P, Caltabiano R, Russo A, Lupo G,
Anfuso CD, Basile MS, Longo A, Nicoletti F, De Pasquale R, Libra M,
et al: Identification of novel chemotherapeutic strategies for
metastatic uveal melanoma. Sci Rep. 7:445642017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Basile MS, Mazzon E, Russo A, Mammana S,
Longo A, Bonfiglio V, Fallico M, Caltabiano R, Fagone P, Nicoletti
F, et al: Differential modulation and prognostic values of
immune-escape genes in uveal melanoma. PLoS One. 14:e02102762019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mangano K, Mazzon E, Basile MS, Di Marco
R, Bramanti P, Mammana S, Petralia MC, Fagone P and Nicoletti F:
Pathogenic role for macrophage migration inhibitory factor in
glioblastoma and its targeting with specific inhibitors as novel
tailored therapeutic approach. Oncotarget. 9:17951–17970. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fagone P, Mangano K, Mammana S, Pesce A,
Pesce A, Caltabiano R, Giorlandino A, Portale TR, Cavalli E,
Lombardo GA, et al: Identification of novel targets for the
diagnosis and treatment of liver fibrosis. Int J Mol Med.
36:747–752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fagone P, Nunnari G, Lazzara F, Longo A,
Cambria D, Distefano G, Palumbo M, Nicoletti F, Malaguarnera L and
Di Rosa M: Induction of OAS gene family in HIV monocyte infected
patients with high and low viral load. Antiviral Res. 131:66–73.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Born TL, Thomassen E, Bird TA and Sims JE:
Cloning of a novel receptor subunit, AcPL, required for
interleukin-18 signaling. J Biol Chem. 273:29445–29450. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Torigoe K, Ushio S, Okura T, Kobayashi S,
Taniai M, Kunikata T, Murakami T, Sanou O, Kojima H, Fujii M, et
al: Purification and characterization of the human interleukin-18
receptor. J Biol Chem. 272:25737–25742. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Salcedo R, Worschech A, Cardone M, Jones
Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O'hUigin C, et al:
MyD88-mediated signaling prevents development of adenocarcinomas of
the colon: Role of interleukin 18. J Exp Med. 207:1625–1636. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lichtblau N, Schmidt FM, Schumann R,
Kirkby KC and Himmerich H: Cytokines as biomarkers in depressive
disorder: Current standing and prospects. Int Rev Psychiatry.
25:592–603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Quak J, Doornbos B, Roest AM, Duivis HE,
Vogelzangs N, Nolen WA, Penninx BW, Kema IP and de Jonge P: Does
tryptophan degradation along the kynurenine pathway mediate the
association between pro-inflammatory immune activity and depressive
symptoms? Psychoneuroendocrinology. 45:202–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Teshigawara T, Mouri A, Kubo H, Nakamura
Y, Shiino T, Okada T, Morikawa M, Nabeshima T, Ozaki N, Yamamoto Y,
et al: Changes in tryptophan metabolism during pregnancy and
postpartum periods: Potential involvement in postpartum depressive
symptoms. J Affect Disord. 255:168–176. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Köhler CA, Freitas TH, Maes M, de Andrade
NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann
N, et al: Peripheral cytokine and chemokine alterations in
depression: A meta-analysis of 82 studies. Acta Psychiatr Scand.
135:373–387. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xu W, Xu Z, Huang L, Qin EQ, Zhang JL,
Zhao P, Tu B, Shi L, Li WG and Chen WW: Transcriptome sequencing
identifies novel immune response genes highly related to the
severity of human adenovirus type 55 infection. Front Microbiol.
10:1302019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dennis C-LE and Stewart DE: Treatment of
postpartum depression, part 1: A critical review of biological
interventions. J Clin Psychiatry. 65:1242–1251. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Frieder A, Fersh M, Hainline R and
Deligiannidis KM: Pharmacotherapy of postpartum depression: Current
approaches and novel drug development. CNS Drugs. 33:265–282.
2019.PubMed/NCBI
|
